Topical stabilized prostaglandin E compound dosage forms
US6841574B2 · kind B2 · utility
23Cited by
14References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2003 |
| Grant date | Jan 11, 2005 |
| Priority date | — |
| Expiry date | Jan 3, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of prostaglandin E group (PGE compounds) are stabilized as non-aqueous compositions that include the compound together with a bulking agent that can be a non-aqueous liquid or a solid in a sheet, film or powder form. The composition can optionally include a skin penetration enhancer. A non-aqueous, solid dosage form comprises a PGE compound substantially uniformly distributed in a carrier sheet or film.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.